Versant Venture Management

Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:

Companies in the Versant Venture Management portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Audentes Therapeutics Inc Com stock 27.20 1.81M 19.14
Achaogen 21.91 1.28M 21.74
Immune Design 16.76 2.21M 9.65
Ocular Therapeutix 16.15 2.22M 9.27
Clovis Oncology 7.51 -74% 101855 93.69
Cymabay Therapeutics 4.75 1.05M 5.76
Second Sight Med Prods 4.42 4.49M 1.25
Opgen 1.30 2.55M 0.65

Past 13F-HR SEC Filings by Versant Venture Management

View All Filings